X4 Pharmaceuticals Inc (XFOR) USD0.001

Sell:$3.90Buy:$4.02$0.05 (1.25%)

Prices delayed by at least 15 minutes
Sell:$3.90
Buy:$4.02
Change:$0.05 (1.25%)
Prices delayed by at least 15 minutes
Sell:$3.90
Buy:$4.02
Change:$0.05 (1.25%)
Prices delayed by at least 15 minutes

Director deals

Listed below are trades carried out by directors and other individuals which are required to be notified to the market.

Recent deals

DateName and position (if held)Deal typeNumber of
shares dealt
Price per
share
Value of
trade
Shares
remaining
23 October 2025
Adam R CraigExecutive Chairman
Buy
Regular purchase transaction
86,206$2.90$249,997.40376,087
24 January 2025
Paula S. RaganPresident/CEO
Sell
Tax related
76,473$0.45$34,718.741,087,386
24 January 2025
Mary DiBiaseCOO
Sell
Tax related
22,258$0.45$10,094.00490,980
24 January 2025
Mark BaldryChief Level Officer
Sell
Tax related
29,159$0.45$13,241.1094,123
24 January 2025
Christophe Arbet-EngelsOther Level A
Sell
Tax related
11,624$0.45$5,284.2714,207
24 January 2025
Adam S MostafaCFO
Sell
Option/Award related
74,773$0.45$33,946.940
15 November 2024
Paula S. RaganPresident/CEO
Sell
Regular sell transaction (market)
31,897$0.39$12,583.37993,919
15 November 2024
Mark BaldryChief Level Officer
Buy
Regular purchase transaction
13,404$0.34$4,597.57129,173

End of results. Director deals are only available for the last 12 months.

5 most significant deals

DateName and position (if held)Deal typeNumber of
shares dealt
Price per
share
Value of
trade
Shares
remaining
23 October 2025
Adam R CraigExecutive Chairman
Buy
Regular purchase transaction
86,206$2.90$249,997.40376,087
24 January 2025
Paula S. RaganPresident/CEO
Sell
Tax related
76,473$0.45$34,718.741,087,386
24 January 2025
Adam S MostafaCFO
Sell
Option/Award related
74,773$0.45$33,946.940
24 January 2025
Mark BaldryChief Level Officer
Sell
Tax related
29,159$0.45$13,241.1094,123
15 November 2024
Paula S. RaganPresident/CEO
Sell
Regular sell transaction (market)
31,897$0.39$12,583.37993,919

Data policy - All information should be used for indicative purposes only. You should independently check data before making any investment decision. HL cannot guarantee that the data is accurate or complete, and accepts no responsibility for how it may be used. Director deal information provided by Factset.